{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 5
    }
  },
  "results": [
    {
      "discontinued_date": "06/17/2026",
      "update_type": "New",
      "initial_posting_date": "06/17/2026",
      "package_ndc": "61958-0601-1",
      "generic_name": "Emtricitabine Capsule",
      "contact_info": "800-445-3235",
      "related_info": "Product expected to be available until March 2027",
      "openfda": {
        "application_number": [
          "NDA021500"
        ],
        "brand_name": [
          "EMTRIVA"
        ],
        "generic_name": [
          "EMTRICITABINE"
        ],
        "manufacturer_name": [
          "Gilead Sciences, Inc."
        ],
        "product_ndc": [
          "61958-0601",
          "61958-0602"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "EMTRICITABINE"
        ],
        "rxcui": [
          "403875",
          "404587",
          "597291",
          "616148"
        ],
        "spl_id": [
          "13ed3577-67a4-4828-b886-f35206f149a6"
        ],
        "spl_set_id": [
          "d6599395-3944-44f9-97f2-e0424c6b6a1f"
        ],
        "package_ndc": [
          "61958-0601-1",
          "61958-0602-1"
        ],
        "nui": [
          "N0000175462",
          "M0015066",
          "N0000009947"
        ],
        "pharm_class_epc": [
          "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_cs": [
          "Nucleosides [CS]"
        ],
        "pharm_class_moa": [
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "unii": [
          "G70B4ETF4S"
        ]
      },
      "update_date": "06/17/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Capsule",
      "presentation": "Emtriva, Capsule, 200 mg (NDC 61958-0601-1)",
      "company_name": "Gilead Sciences, Inc.",
      "status": "To Be Discontinued"
    }
  ]
}